The $460 million "remedy" flopped.
Spitzer's independent-stock-research mandate
Related Entries:
- Martin Act abuses
- Around the web, April 22
- Around the web, August 25
- Spitzer: let's use public pension funds to annihilate U.S. Chamber
- New featured column: "Greenberg's Settlement, Spitzer's Folly"
- Spitzer vs. Grasso, a post-mortem
- Cuomo as Wall Street enforcer
- If you're not reading Overlawyered...
- "The cost of Spitzerism"
- "On the Tort Reform Angle, Too Bad about Spitzer"
- "Radioactive in this environment"
- Spitzer scandal, around the web
- Customer No. 9, or the fall of Spitzer?
- Well, that sure worked out well
![]() |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
![]() |
| Laura Eyi Press Officer, Manhattan Institute leyi@manhattan-institute.org |



